Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-40,194
Closed -$317K 1642
2024
Q3
$317K Buy
40,194
+19,799
+97% +$178K 0.02% 990
2024
Q2
$210K Buy
20,395
+6,309
+45% +$68.3K 0.01% 1167
2024
Q1
$176K Buy
+14,086
New +$182K 0.01% 1187
2023
Q4
Sell
-25,475
Closed -$374K 1631
2023
Q3
$374K Buy
+25,475
New +$397K 0.04% 675
2023
Q2
Sell
-13,317
Closed -$237K 1713
2023
Q1
$237K Buy
13,317
+281
+2% +$5.25K 0.03% 878
2022
Q4
$255K Buy
+13,036
New +$264K 0.04% 730

Other funds holding TBI

Y-Intercept (HK)'s TBI Position: Q4 2024 in Review

Y-Intercept (HK) sold out of Trueblue (TBI) in Q4 2024, closing a stake of 40,194 shares — an estimated $317K sold.

Y-Intercept (HK) first reported a position in TBI in Q4 2022 and held it in 6 quarters. The position peaked at $374K in Q3 2023. 117 funds tracked by Wall St. Rank hold TBI as of Q4 2024.

  • Y-Intercept (HK) reported no remaining Trueblue position as of Q4 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 40,194 Trueblue shares in Q4 2024, an estimated $317K.
  • Y-Intercept (HK) first reported a position in Trueblue in Q4 2022 and held it in 6 quarters.
  • Y-Intercept (HK)'s Trueblue position peaked at $374K in Q3 2023.
  • 117 funds tracked by Wall St. Rank held Trueblue as of Q4 2024.

Based on Y-Intercept (HK)'s 13F filing for Q4 2024, filed 4 Feb 2025.